Arsenal Capital Partners is acquiring ThermoSafe from Sonoco Products Company for up to $725 million, enhancing its portfolio in the growing temperature-controlled packaging sector.

Information on the Target

ThermoSafe, a prominent business unit of Sonoco Products Company, specializes in delivering temperature-controlled packaging solutions. The company’s expertise plays a crucial role in the safe and efficient transport of a variety of temperature-sensitive products, including pharmaceuticals, biologics, and vaccines. As one of the leading providers in its field, ThermoSafe is recognized for its commitment to quality and innovation, enhancing the logistics of critical health-related products.

Under the terms of the definitive agreement, private equity firm Arsenal Capital Partners will acquire ThermoSafe for a total purchase price of up to $725 million. This price includes an upfront payment of $650 million, structured on a cash-free and debt-free basis, with potential additional payments of up to $75 million contingent on meeting certain performance metrics in the year 2025.

Industry Overview

The temperature-controlled packaging industry has witnessed significant growth in recent years, driven primarily by the increasing demand for efficient logistics in the pharmaceutical and biotech sectors.